SLAMF8 and central nervous system cancer: The SLAM family, a subset of the broader CD2 protein family, exhibits differential expression on the surface of immune cells [31].SLAMF8, a type I cell surface glycoprotein, has been observed to be overexpressed in conjunction with malignancy progression and serves as a biomarker for the mesenchymal subtype of glioma [17].